Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

ERRATA
Page 36: In Table 2 in the column “Method”:
Third cell (Haapasaari et al. 1998) should be: SBF
Serum
Fourth cell (Koivukangas et al. 1995) should be: SBF
Page 41: The following paragraph is missing:
Control groups
In study II, two control groups were matched demographically and clinically to the
primary study group. Outpatients from our clinic with moderate-to-severe atopic
dermatitis who were undergoing long-term intermittent treatment with topical
corticosteroids, mostly of intermediate potency, comprised the conventional therapy
group. In this group, a treatment period of two to three weeks was followed by at least a
one-week period without treatment when clinically possible. Some of these patients
received additional treatments such as ciclosporin (3 patients) and UV-light therapy (2
patients). Twenty-seven healthy subjects with no known skin or other diseases were
used as controls representing normal skin.
In study III, a randomly selected group of 49 volunteer medical students or
personnel of similar age but without AD or current airway symptoms were used as
control subjects. Data on age, sex, smoking status, atopy status by skin prick tests
(SPT), and medical history were collected from all subjects. Lung function tests were
performed to all 49 and induced sputum to a subgroup of 19 volunteer control subjects.
Page 49: The correct legend for Figure 1 is:
Figure 1. Combined levels of PINP and PIIINP in healthy controls and patients
treated with corticosteroids or tacrolimus ointment 0.1% monotherapy. H)
healthy controls, N=27; C0) corticosteroid treated patients, N=36, at baseline
and C12) after 12 months; T0) tacrolimus treated patients, N=56, at baseline,
T12) after 12 months, and T24) after 24 months.